Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.26
Delayed Data
As of Mar 27
 -0.0222 / -7.87%
Today’s Change
0.23
Today|||52-Week Range
0.38
-28.77%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.28
Today’s open0.28
Day’s range0.25 - 0.28
Volume322,893
Average volume (3 months)182,766
Market cap$12.5M
Dividend yield--
Data as of 3:46pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-24.62%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-44.00%
P/E ratio0.7
Price/Sales1.73
Price/Book0.69

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.5M
Annual profit (last year)$21.6M
Net profit margin123.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts


Search for Jobs